A PhaseⅠ, Randomized, Observer-blinded, Active Comparator, First-in-human Clinical Trial to Evaluate Safety and Tolerability of Herpes Zoster Vaccine EuHZV in Healthy Adults Aged 50 to 69 Years
Latest Information Update: 19 Jul 2024
At a glance
- Drugs EuHZV (Primary)
- Indications Herpes zoster; Varicella zoster virus infections
- Focus Adverse reactions; First in man
- Sponsors EuBiologics
- 16 Jul 2024 Status changed from not yet recruiting to recruiting.
- 14 Jun 2024 Planned initiation date changed from 17 Jun 2024 to 31 Jul 2024.
- 17 May 2024 New trial record